Help
RSS
API
Feed
Maltego
Contact
Domain > www.oragenics.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2016-06-06
52.7.79.183
(
ClassC
)
2022-01-30
3.225.74.242
(
ClassC
)
2025-02-27
23.21.250.185
(
ClassC
)
2025-12-06
52.9.119.45
(
ClassC
)
Port 443
HTTP/1.1 200 OKDate: Sat, 06 Dec 2025 00:27:24 GMTServer: ApacheVary: Accept-EncodingTransfer-Encoding: chunkedContent-Type: text/html; charsetUTF-8 !DOCTYPE html>!--if lt IE 7> html classno-js lt-ie9 lt-ie8 lt-ie7 langen> !endif-->!--if IE 7> html classno-js lt-ie9 lt-ie8 langen> !endif-->!--if IE 8> html classno-js lt-ie9 langen> !endif-->!--if gt IE 8>!--> html classno-js langen> !--!endif--> head> meta charsetutf-8> title>Oragenics, Inc. (OGEN)/title> meta nameviewport contentinitial-scale1.0, widthdevice-width> !-- Fonts --> link relstylesheet hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/css/fonts.css> !-- Stylesheets --> link relstylesheet hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/css/bootstrap.min.css> link relstylesheet hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/css/bootstrap-select.min.css> link relstylesheet hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/css/fancybox.css> link relstylesheet hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/css/ir-default.css> link relstylesheet hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/css/style.css> !-- Favicons --> link relapple-touch-icon sizes57x57 hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/favicons/apple-touch-icon-57x57.png> link relapple-touch-icon sizes60x60 hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/favicons/apple-touch-icon-60x60.png> link relapple-touch-icon sizes72x72 hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/favicons/apple-touch-icon-72x72.png> link relapple-touch-icon sizes76x76 hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/favicons/apple-touch-icon-76x76.png> link relapple-touch-icon sizes114x114 hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/favicons/apple-touch-icon-114x114.png> link relapple-touch-icon sizes120x120 hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/favicons/apple-touch-icon-120x120.png> link relapple-touch-icon sizes144x144 hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/favicons/apple-touch-icon-144x144.png> link relapple-touch-icon sizes152x152 hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/favicons/apple-touch-icon-152x152.png> link relapple-touch-icon sizes180x180 hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/favicons/apple-touch-icon-180x180.png> link relicon typeimage/png hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/favicons/favicon-32x32.png sizes32x32> link relicon typeimage/png hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/favicons/favicon-194x194.png sizes194x194> link relicon typeimage/png hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/favicons/favicon-96x96.png sizes96x96> link relicon typeimage/png hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/favicons/android-chrome-192x192.png sizes192x192> link relicon typeimage/png hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/favicons/favicon-16x16.png sizes16x16> link relmanifest hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/favicons/manifest.json> link relmask-icon hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/favicons/safari-pinned-tab.svg> link relshortcut icon hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/favicons/favicon.ico> meta namemsapplication-TileColor content#ffffff> meta namemsapplication-TileImage contenthttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/favicons/mstile-144x144.png> meta namemsapplication-config contenthttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/favicons/browserconfig.xml> meta nametheme-color content#97c21c> !--if lt IE 9>link relstylesheet hrefhttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/css/ie-8.css>!endif--> script srchttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/js/aside/_js/modernizr.custom.70273.min.js>/script> !-- Google GA4 code (gtag.js) -->script async srchttps://www.googletagmanager.com/gtag/js?idG-WYXMNJNFG3>/script>script> window.dataLayer window.dataLayer || ; function gtag(){dataLayer.push(arguments);} gtag(js, new Date()); gtag(config, G-WYXMNJNFG3); /script>!-- END Google GA4 code (gtag.js) --> /head>body classhome> header> div classmain-header clearfix> h1 classlogo hidden-md hidden-lg> a href/> img srchttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/oragenics-logo-white.svg width240 height50 altOragenics, Inc.> /a> /h1> a classvisible-xs mobile-nav-trigger idshowRight> div classmeat>/div> div classmeat>/div> div classmeat>/div> /a> nav classcbp-spmenu cbp-spmenu-vertical cbp-spmenu-right main-nav idmobile-nav> ul classheader-nav> li classsr-only>a href/>Home/a>/li> li classhas-children first data-submenu-idsubmenu-pharmaceuticals> a classnav-color--white href/pharmaceuticals>Pharmaceuticals/a> ul idsubmenu-pharmaceuticals> li class >a href/pharmaceuticals/brain-related-drug-development>Brain Related Drug Development/a>/li> /ul> /li> li classhas-children data-submenu-idsubmenu-technology-pipeline> a classnav-color--white href/technology-pipeline>Technology & Pipeline/a> ul idsubmenu-technology-pipeline> li class >a href/technology-pipeline/pipeline>Pipeline/a>/li> li class >a href/technology-pipeline/vaccine-program>Vaccine Program/a>/li> li class >a href/technology-pipeline/science-technology>Science & Technology/a>/li> /ul> /li> li classlogo-center> a classvisible-md visible-lg href/>img srchttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/oragenics-logo-white.svg altOragenics Inc>/a> /li> li classhas-children data-submenu-idsubmenu-news-media> a classnav-color--white href/news-media>News & Media/a> ul idsubmenu-news-media> li class >a href/news-media/press-releases>Press Releases/a>/li> li class >a href/news-media/in-the-news>In The News/a>/li> li class >a href/news-media/media>Media/a>/li> li class >a href/news-media/presentations>Presentations/a>/li> li class >a href/news-media/publications>Publications/a>/li> li class >a href/news-media/abstracts>Abstracts/a>/li> /ul> /li> li classhas-children has-mega-menu data-submenu-idsubmenu-investors> a classnav-color--white href/investors>Investors/a> div classmega-menu second-level same-height-row-disabled> div classcontainer> ul classheight> li classtitle>a href/investors>Investor Relations/a>/li> li>a href/investors/_>Overview/a>/li> /ul> ul classheight> li classtitle>a href/investors/news-events>News / Events/a>/li> li>a href/investors/news-events/press-releases>Press Releases/a>/li> li>a href/investors/news-events/email-alerts>Email Alerts/a>/li> li>a href/investors/news-events/ir-calendar>Events/a>/li> /ul> ul classheight> li classtitle>a href/investors/company-information>Company Info/a>/li> li>a href/investors/company-information/profile>Profile/a>/li> li>a href/investors/company-information/presentations>Presentations/a>/li> li>a href/investors/company-information/management-team>Management Team/a>/li> li>a href/investors/company-information/contacts>Contacts/a>/li> li>a href/investors/company-information/faq>FAQ/a>/li> /ul> ul classheight> li classtitle>a href/investors/financial-information>Financial Info/a>/li> li>a href/investors/financial-information/financials>Financials/a>/li> li>a href/investors/financial-information/financial-results>Financial Results/a>/li> /ul> ul classheight> li classtitle>a href/investors/stock-data>Stock Data/a>/li> li>a href/investors/stock-data/quote>Quote/a>/li> li>a href/investors/stock-data/charts>Charts/a>/li> li>a href/investors/stock-data/historical-data>Historical Data/a>/li> /ul> ul classheight> li classtitle>a href/investors/sec-filings>SEC Filings/a>/li> li>a href/investors/sec-filings/all-sec-filings>All SEC Filings/a>/li> li>a href/investors/sec-filings/annual-reports>Annual Reports/a>/li> li>a href/investors/sec-filings/quarterly-reports>Quarterly Reports/a>/li> li>a href/investors/sec-filings/section-16-filings>Section 16 Filings/a>/li> /ul> ul classheight> li classtitle>a href/investors/corporate-governance>Governance/a>/li> li>a href/investors/corporate-governance/board-of-directors>Board of Directors/a>/li> li>a href/investors/corporate-governance/board-committees>Board Committees/a>/li> li>a href/investors/corporate-governance/governance-docs>Governance Documents/a>/li> /ul> /div>/div> /li> li classhas-children data-submenu-idsubmenu-about> a classnav-color--white href/about>About/a> ul idsubmenu-about> li class >a href/about>Overview/a>/li> li class >a href/about/management-team>Management Team/a>/li> li class >a href/about/board-of-directors>Board of Directors/a>/li> li class >a href/about/scientific-advisors>Scientific Advisors/a>/li> li class >a href/about/contact-us>Contact Us/a>/li> /ul> /li> /ul> /nav> /div> !-- Latest News Header -->div classlatest-news dark visible-sm visible-md visible-lg> a hrefhttps://www.oragenics.com/news-media/press-releases/detail/222/oragenics-q3-2025-shareholder-update classnews-container> h3>Latest News/h3> span classpost-date>Nov 12, 2025/span> span classnews-title>Oragenics Q3 2025 Shareholder Update/span> /a>/div>!-- /Latest News Header -->/header> div classcycle-slideshow slider-home data-cycle-manual-fxfade data-cycle-fxfade data-cycle-pause-on-hovertrue data-cycle-slides> .slide-item data-cycle-swipetrue data-cycle-timeout500000 data-cycle-logfalse data-cycle-pager#cycle-pager data-cycle-prev#prev data-cycle-next#next>div classslide-item> div classhome-hero background overlay active > !-- Display Video --> div classhome-hero--video-overlay>/div> video autoplay muted loop> source srchttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/db/197/699/video/banner+video.mp4 typevideo/mp4> Your browser does not support the video tag. /video> !-- END Display Video --> div classcontainer vertical-align> div classwrapper text> div classrow> div classcol-md-12 media-video-text> div classcol-md-12> h2 classtext-center> On the Cutting Edge /h2> p>Oragenics is striving to revolutionize neurological care through proprietary intranasal delivery technology that has the potential to enable targeted, non-invasive therapeutics for brain-related conditions. Our lead candidate, ONP-002, is advancing with the goal of becoming the first FDA-approved treatment for concussion, while our platform technology has the potential, we believe, to open pathways to address neurodegenerative diseases, CNS disorders, and other neurological conditions./p>p>We’re building more than a pharmaceutical company—we’re creating a movement around brain-first recovery that transforms how patients, clinicians, and healthcare systems approach neurological trauma./p> /div> /div> div classcol-md-8 col-md-offset-2 media-video> video controls> source srchttps://d1io3yog0oux5.cloudfront.net/_c78020cc0fe5e33b9b42220ebc4857a9/oragenics/files/media/e568a725f92fbd3f2e5b04604966dec2.mp4 typevideo/mp4> Your browser does not support the video tag. /video> /div> /div> /div> /div> /div>!-- // slide -->/div>/div> !-- Sign Up Bar --> div classsignup-bar dark> div classcontainer center> h3>Sign up for email updates/h3> p>Be the first to receive breaking news/p> a href/email-alerts classbtn-gradient>span>Sign Up/span>/a> /div> /div> !-- Sign Up Bar --> !-- Investors Information--> div classinvestors-information> div classcontainer> div classrow > div classcol-md-5 view-info-block news-block js-same-height> div classcenter-block vertical-align js-same-height> h3>Recent News/h3> div classrecent-new> div classevent-date> time datetimeNov 12, 2025>Nov 12, 2025/time> /div> a hrefhttps://www.oragenics.com/news-media/press-releases/detail/222/oragenics-q3-2025-shareholder-update>Oragenics Q3 2025 Shareholder Update/a>/div>div classrecent-new> div classevent-date> time datetimeOct 21, 2025>Oct 21, 2025/time> /div> a hrefhttps://www.oragenics.com/news-media/press-releases/detail/221/oragenics-regains-full-nyse-american-compliance-company>Oragenics Regains Full NYSE American Compliance, Company Resolves Stockholder Equity Deficiency/a>/div> /div> /div> div classcol-md-7 view-info-block no-border quote-box js-same-height data-symbolOGEN> div classcenter-block vertical-align> div classwrapper> div classinvestors-title clearfix> h3>Stock Data/h3> span classmeta> span classtime>time datetime>/time>/span> a hrefhttps://ir.oragenics.com> View Investor Relations/a> /span> /div> div classinvestors-numbers quote-box clearfix> div classstock-section name> span classvalue-title>NYSE American/span> span classvalue>OGEN/span> /div> div classstock-section price> span classvalue-title>Price/span> span classvalue> img srchttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/ajax-loader.gif altLoading...> /span> /div> div classstock-section change> span classvalue-title>Change/span> span classvalue>span classeqicon-change-02>/span>span classnumber> img srchttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/ajax-loader.gif altLoading...> /span>/span> /div> div classstock-section day-range> span classvalue-title>Day Range/span> span classvalue> img srchttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/ajax-loader.gif altLoading...> /span> /div> div classstock-section week-range> span classvalue-title>52 Wk Range/span> span classvalue> img srchttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/images/ajax-loader.gif altLoading...> /span> /div>br> span classmeta> Last Updated: span classtime>time datetime>/time>/span> /span> /div> /div> /div> /div> /div> /div> /div> !-- /Investors Information --> footer> div classcontainer> div classcopy-menu> span classcopyright> © 2025 a href/>Oragenics, Inc./a> All Rights Reserved. /span> div classfooter-menu> ul> li>a href/privacy-policy>Privacy Policy/a> li>a href/disclaimer>Disclaimer/a> li>a href/sitemap>Sitemap/a> li>a hrefhttps://ir.oragenics.com/email-alerts classbtn-gradient>span>Email Alerts/span>/a>/li> /ul> /div> /div> /div>/footer>!-- for hCaptcha -->script idcompanyVars typeapplication/json>{ hCaptchaSiteKey: 778a5748-d323-4b73-a06c-9625642de8bc}/script>script srchttps://d1io3yog0oux5.cloudfront.net/_5beab8c4cb06884fb20d2878e7665a8e/oragenics/files/js/_js/all.js>/script>script typetext/javascript> var jqxhr $.get( https://www.oragenics.com/api/v1/quote, function(data) { populateQuoteBox(data); });/script>script> var $buoop { c: 2 }; function $buo_f() { var e document.createElement(script); e.src //browser-update.org/update.min.js; document.body.appendChild(e); } try { document.addEventListener(DOMContentLoaded, $buo_f, false) } catch (e) { window.attachEvent(onload, $buo_f) }/script>/body>
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]